Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA023392 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA023392, RRID:AB_1847740
- Product name
- Anti-DLL4
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human DLL4, Gene description: delta-like 4 (Drosophila), Validated applications: IHC, Uniprot ID: Q9NR61, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references HROB Is Implicated in DNA Replication
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer
Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation
Kutz J, Schmietendorf H, Rahman S, Opel F, Pospiech H
Genes 2024;15(12):1587
Genes 2024;15(12):1587
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
Park S, Kim J, Jang W, Kim K, Jang K
Journal of Pathology and Translational Medicine 2023;57(2):113-122
Journal of Pathology and Translational Medicine 2023;57(2):113-122
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer
Kim Y, Byeon S, Hur J, Lee K, Kim D, Ahn J, Lee S, You W, Kim S, Park S, Kang W, Kim K, Lee J
Journal of Cancer 2019;10(14):3172-3178
Journal of Cancer 2019;10(14):3172-3178
Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation
Vo K, Amarasinghe B, Washington K, Gonzalez A, Berlin J, Dang T
Molecular Cancer 2011;10(1)
Molecular Cancer 2011;10(1)
No comments: Submit comment
No validations: Submit validation data